Creative Medical Technology Holdings (CELZ) Stock Statistics & Valuation Metrics
Total Valuation
Creative Medical Technology Holdings has a market cap or net worth of $4.32M. The enterprise value is $57.50B.
- Market Cap
- $4.32M
- Enterprise Value
- $57.50B
Share Statistics
Creative Medical Technology Holdings has 6,592,557 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 6,592,557
- Owned by Insiders
- 15.70%
- Owned by Institutions
- 3.22%
Financial Efficiency
Creative Medical Technology Holdings’s return on equity (ROE) is -0.80 and return on invested capital (ROIC) is -81.48%.
- Return on Equity (ROE)
- -0.80
- Return on Assets (ROA)
- -0.77
- Return on Invested Capital (ROIC)
- -81.48%
- Return on Capital Employed (ROCE)
- -0.82
- Revenue Per Employee
- 1,500
- Profits Per Employee
- -1.50M
- Employee Count
- 4
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Creative Medical Technology Holdings is -0.33. Creative Medical Technology Holdings’s PEG ratio is -0.01.
- PE Ratio
- -0.33
- PS Ratio
- 563.44
- PB Ratio
- 0.28
- Price to FCF
- -0.29
- Price to Operating Cash Flow
- -0.41
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Creative Medical Technology Holdings had revenue of 6,000 and earned -6.00M in profits. Earnings per share was -2.52.
- Revenue
- 6,000
- Gross Profit
- 3,806
- Operating Income
- -6.14M
- Pretax Income
- -6.00M
- Net Income
- -6.00M
- EBITDA
- -6.02M
- Earnings Per Share (EPS)
- -2.52
Cash Flow
In the last 12 months, operating cash flow was -5.90M and capital expenditures 4, giving a free cash flow of -5.90M billion.
- Operating Cash Flow
- -5.90M
- Free Cash Flow
- -5.90M
- Free Cash Flow per Share
- -1.59
Dividends & Yields
Creative Medical Technology Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -349.15%
- Earnings Yield
- -249.14%
Stock Price Statistics
- Beta
- 1.60
- 52-Week Price Change
- -79.97%
- 50-Day Moving Average
- 0.93
- 200-Day Moving Average
- 1.57
- Relative Strength Index (RSI)
- 32.44
- Average Volume (3m)
- 6.74M
Financial Position
Creative Medical Technology Holdings as a current ratio of 25.97, with Debt / Equity ratio of 0.19%
- Current Ratio
- 25.97
- Quick Ratio
- 25.97
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 1.20
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Creative Medical Technology Holdings has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Creative Medical Technology Holdings EV to EBITDA ratio is 1.15, with an EV/FCF ratio of 1.19.
- EV to Sales
- -2341.26
- EV to EBITDA
- 1.15
- EV to Free Cash Flow
- 1.19
- EV to Operating Cash Flow
- 1.19
Balance Sheet
Creative Medical Technology Holdings has $8.71M in cash and marketable securities with $0.00 in debt, giving a net cash position of $8.71M billion.
- Cash & Marketable Securities
- $8.71M
- Total Debt
- $0.00
- Net Cash
- $8.71M
- Net Cash Per Share
- $1.32
- Tangible Book Value Per Share
- $2.25
Margins
Gross margin is -1732.37%, with operating margin of -208004.40%, and net profit margin of -201355.37%.
- Gross Margin
- -1732.37%
- Operating Margin
- -208004.40%
- Pretax Margin
- -201285.83%
- Net Profit Margin
- -201355.37%
- EBITDA Margin
- -202975.03%
- EBIT Margin
- -206767.73%
Analyst Forecast
The average price target for Creative Medical Technology Holdings is $20.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- $20.00
- Price Target Upside
- 2953.44% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 1
- Revenue Growth Forecast
- -50.00%
- EPS Growth Forecast
- 44.01%
